Clin2
NCT05491395Possibly a fitRecruiting

Radiation after mastectomy with breast implant reconstruction

Breast Cancer

Part of Cancer, Skin clinical trials.

This trial studies a radiation schedule given after breast cancer surgery when your breast was rebuilt right away with a prosthesis (implant or similar). It aims to see whether this “hypofractionated” (fewer, larger treatment sessions) radiation approach is appropriate for patients who need additional (adjuvant) radiation to reduce recurrence risk.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have breast cancer confirmed by biopsy as invasive ductal cancer or invasive lobular cancer.
  • You had a radical mastectomy (breast removed) with immediate reconstruction using a prosthesis/implant.
  • Your doctors recommend adjuvant (after-surgery) radiation therapy, not treatment meant only to relieve symptoms.
  • You are an adult (over 18) and can do daily activities at a level that fits ECOG 0 to 2 (generally fully active to limited but up-and-about).
  • Your cancer has not spread to distant parts of the body (no distant metastases).
  • You have not had other past cancers, and you have not had prior radiation or chemotherapy before starting this study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06830083Recruiting
Shorter radiation schedule after mastectomy with implant reconstruction

This trial is testing a shorter, higher-dose radiation schedule (hypofractionation) for women who have had a mastectomy and immediate breast reconstruction with implants. The goal is to see if this approach works as well as standard radiation while possibly being more convenient and causing fewer side effects.

Nanjing, Jiangsu
NCT07084519Recruiting· Phase 3
Short vs standard radiation after mastectomy with implant reconstruction

This trial compares standard radiation therapy to a shorter course (hypofractionated) for women who have had a mastectomy with implant reconstruction. The goal is to see if the shorter schedule works as well while possibly reducing side effects for the reconstructed breast.

Beijing, Province
NCT05692674Recruiting· Phase 2
Proton radiation after breast surgery with implant reconstruction

This trial studies a type of radiation made with proton beams given after mastectomy and implant reconstruction to lower breast cancer coming back. It’s for people who need additional (adjuvant) radiation and have not had prior radiation to the chest or breast.

Shanghai, Shanghai Municipality
NCT07835139Recruiting
Shorter radiation schedule after breast implant reconstruction surgery

This trial compares a shorter course of radiation (fewer, larger doses) with the standard longer course for women who have had breast cancer surgery with implant-based reconstruction. It aims to see if the shorter schedule is just as safe and effective for the chest area, while being more convenient.

Shanghai
NCT05253170Not yet recruiting· Phase 3
Shorter versus standard radiation after mastectomy with reconstruction

This trial compares two different schedules of radiation therapy after mastectomy and breast reconstruction. One uses standard daily doses over a longer period, and the other uses higher doses over a shorter period. The goal is to see if the shorter schedule works just as well while possibly saving time and reducing side effects.

NCT07831889Not yet recruiting
Short-course radiation after breast reconstruction

This study tests a shorter course of radiation therapy after breast reconstruction surgery for people with breast cancer. It aims to see if fewer, larger doses of radiation are safe and effective after mastectomy with reconstruction.

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.